Abatacept Clinical Trials
13 recruitingDrug
Phase 28Phase 34Phase 14Early Phase 11
Showing 1–13 of 13 trials
Recruiting
Phase 1Phase 2
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Beta-ThalassemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)90 enrolled1 locationNCT07599176
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
Phase 3
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University400 enrolled6 locationsNCT06654882
Recruiting
Phase 1Phase 2
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Graft-Versus-Host Disease
Northwell Health74 enrolled1 locationNCT05289167
Recruiting
Phase 2
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Graft vs Host Disease
Boston Children's Hospital160 enrolled15 locationsNCT04380740
Recruiting
Phase 1
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Graft vs Host DiseaseGraft-Versus-Host Disease
Washington University School of Medicine41 enrolled1 locationNCT06008808
Recruiting
Phase 2
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled15 locationsNCT05917522
Recruiting
Phase 3
Abatacept for the Treatment of Giant Cell Arteritis
Giant Cell Arteritis
University of Pennsylvania78 enrolled9 locationsNCT04474847
Recruiting
Phase 2Phase 3
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology64 enrolled1 locationNCT07366801
Recruiting
Early Phase 1
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Hematologic Malignancy
Duke University10 enrolled1 locationNCT06731504
Recruiting
Phase 2
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung DiseaseCommon Variable Immunodeficiency
Children's Hospital Medical Center, Cincinnati38 enrolled6 locationsNCT04925375
Recruiting
Phase 2
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Hodgkin LymphomaLymphomaAcute Myelogenous Leukemia+5 more
Leland Metheny20 enrolled1 locationNCT06680661
Recruiting
Phase 1Phase 2
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Thalassemia in Children
The Hospital for Sick Children20 enrolled1 locationNCT05426252